Agreement among HLA antibody detection assays is higher in ever-pregnant donors and improved using a consensus cutoff

Transfusion

Volumn 51, Issue 5, 2011, Pages 1105-1116

  Carrick, Danielle M ^b   Johnson, Bryce ^b   Kleinman, Steven H ^b   Vorhaben, Robert ^b   Chance, Suzette C ^b   Lee, Jar How ^b   Roback, John D ^b   Pandey, Suchitra ^b   Sun, Yu ^b   Busch, Michael P ^b   Norris, Philip J ^a  

^a BLOOD SYSTEMS RESEARCH INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2;

ANTIBODY DETECTION; ARTICLE; BLOOD SAMPLING; CONSENSUS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HLA SYSTEM; HUMAN; IMMUNOASSAY; MALE; PREGNANCY; PREGNANT WOMAN;

ACUTE LUNG INJURY; ANTIBODIES; BLOOD DONORS; BLOOD TRANSFUSION; CONSENSUS; CROSS-SECTIONAL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; LEUKOCYTES; MALE; MODELS, STATISTICAL; PREGNANCY; PROSPECTIVE STUDIES; RISK FACTORS; SEROEPIDEMIOLOGIC STUDIES;

EID: 79955657421     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2010.02938.x     Document Type: Article

References (29)

1. Payne R,. The development and persistence of leukoagglutinins in parous women. Blood 1962; 19: 411-24.
2. Howard JE, Perkins HA,. The natural history of alloimmunization to platelets. Transfusion 1978; 18: 496-503. (Pubitemid 9056062)
3. Reed E, Hardy M, Benvenisty A, Lattes C, Brensilver J, McCabe R, Reemstma K, King DW, Suciu-Foca N,. Effect of antiidiotypic antibodies to HLA on graft survival in renal-allograft recipients. N Engl J Med 1987; 316: 1450-5. (Pubitemid 17079093)
4. Slichter SJ, Davis K, Enright H, Braine H, Gernsheimer T, Kao KJ, Kickler T, Lee E, McFarland J, McCullough J, Rodey G, Schiffer CA, Woodson R,. Factors affecting posttransfusion platelet increments, platelet refractoriness, and platelet transfusion intervals in thrombocytopenic patients. Blood 2005; 105: 4106-14. (Pubitemid 40656162)
5. Holness L, Knippen MA, Simmons L, Lachenbruch PA,. Fatalities caused by TRALI. Transfus Med Rev 2004; 18: 184-8. (Pubitemid 38962487)
6. Starkey J, Kapler R,. transfusion recipient fatalities reported to the food and drug administration, FY2004-2006. Washington, DC: ABC Newsletter 2007; 14: 21.
7. Silliman CC, Boshkov LK, Mehdizadehkashi Z, Elzi DJ, Dickey WO, Podlosky L, Clarke G, Ambruso DR,. Transfusion-related acute lung injury: epidemiology and a prospective analysis of etiologic factors. Blood 2003; 101: 454-62. (Pubitemid 36077563)
8. Davoren A, Curtis BR, Shulman IA, Mohrbacher AF, Bux J, Kwiatkowska BJ, McFarland JG, Aster RH,. TRALI due to granulocyte-agglutinating human neutrophil antigen-3a (5b) alloantibodies in donor plasma: a report of 2 fatalities. Transfusion 2003; 43: 641-5. (Pubitemid 36506361)
9. Silliman CC, Curtis BR, Kopko PM, Khan SY, Kelher MR, Schuller RM, Sannoh B, Ambruso DR,. Donor antibodies to HNA-3a implicated in TRALI reactions prime neutrophils and cause PMN-mediated damage to human pulmonary microvascular endothelial cells in a two-event in vitro model. Blood 2007; 109: 1752-5. (Pubitemid 46239611)
10. Popovsky MA, Moore SB,. Diagnostic and pathogenetic considerations in transfusion-related acute lung injury. Transfusion 1985; 25: 573-7. (Pubitemid 16174471)
11. Kopko P, Silva M, Shulman I, Kleinman S,. AABB survey of transfusion-related acute lung injury policies and practices in the United States. Transfusion 2007; 47: 1679-85. (Pubitemid 47300624)
12. Terasaki PI, McClelland JD,. Microdroplet assay of human serum cytotoxins. Nature 1964; 204: 998-1000.
13. Phelan DL, Rodey GE, Anderson CB,. The development and specificity of antiidiotypic antibodies in renal transplant recipients receiving single-donor blood transfusions. Transplantation 1989; 48: 57-60. (Pubitemid 19194037)
14. Uboldi de Capei M, Pratico L, Curtoni ES,. Comparison of different techniques for detection of anti-HLA antibodies in sera from patients awaiting kidney transplantation. Eur J Immunogenet 2002; 29: 379-82. (Pubitemid 35177199)
15. Pei R, Lee J, Chen T, Rojo S, Terasaki PI,. Flow cytometric detection of HLA antibodies using a spectrum of microbeads. Hum Immunol 1999; 60: 1293-302. (Pubitemid 30017514)
16. Wahrmann M, Exner M, Haidbauer B, Schillinger M, Regele H, Körmöczi G, Böhmig GA,. [C4d]FlowPRA screening-a specific assay for selective detection of complement-activating anti-HLA alloantibodies. Hum Immunol 2005; 66: 526-34. (Pubitemid 40797551)
17. Triulzi DJ, Kleinman S, Kakaiya RM, Busch MP, Norris PJ, Steele WR, Glynn SA, Hillyer CD, Carey P, Gottschall JL, Murphy EL, Rios JA, Ness PM, Wright DJ, Carrick D, Schreiber GB,. The effect of previous pregnancy and transfusion on HLA alloimmunization in blood donors: implications for a transfusion-related acute lung injury risk reduction strategy. Transfusion 2009; 49: 1825-35.
18. Bollen KA,. Structural equations wtih latent variables. New York: John Wiley & Sons; 1989.
19. Joreskog KG, Sorbom D, Wallentin FY,. Latent Variable Scores and Observational Residuals [monograph on the internet]. 2006. [cited 22 April 2010] Available from URL
20. Powers A, Stowell CP, Dzik WH, Saidman SL, Lee H, Makar RS,. Testing only donors with a prior history of pregnancy or transfusion is a logical and cost-effective transfusion-related acute lung injury prevention strategy. Transfusion 2008; 48: 2549-58.
21. Kleinman S, Grossman B, Kopko P,. A national survey of transfusion-related acute lung injury risk reduction policies for platelets and plasma in the United States. Transfusion 2010; 50: 1312-21.
22. Worthington JE, Robson AJ, Sheldon S, Langton A, Martin S,. A comparison of enzyme-linked immunoabsorbent assays and flow cytometry techniques for the detection of HLA specific antibodies. Hum Immunol 2001; 62: 1178-84. (Pubitemid 32971397)
23. Lopes LB, Fabron-Jr A, Chiba AK, Ruiz MO, Bordin JO,. Impact of using different laboratory assays to detect human leukocyte antigen antibodies in female blood donors. Transfusion 2010; 50: 902-8.
24. Fadeyi E, Adams S, Peterson B, Hackett J, Byrne P, Klein HG, Marincola FM, Leitman SF, Stroncek DF,. Analysis of a high-throughput HLA antibody screening assay for use with platelet donors. Transfusion 2008; 48: 1174-9. (Pubitemid 351793496)
25. Vassallo RR, Hsu S, Einarson M, Barone J, Brodsky J, Moroff G,. A comparison of two robotic platforms to screen plateletpheresis donors for HLA antibodies as part of a transfusion-related acute lung injury mitigation strategy. Transfusion 2010; 50: 1766-77.
26. Morales-Buenrostro LE, Terasaki PI, Marino-Vazquez LA, Lee JH, El-Awar N, Alberà J,. "Natural" human leukocyte antigen antibodies found in nonalloimmunized healthy males. Transplantation 2008; 86: 1111-5.
27. Book BK, Higgins NG, Rosner KM, Pescovitz MD,. Impact of anticoagulant in samples for HLA antibody screening by Luminex. Hum Immunol 2008; 69: S35.
28. Heinold A, Kuehl B, Brenner-Weiss G, Opelz G, Tran TH,. Sequential analysis by immunoprecipitation-MALDI-TOF: a novel method for detection and identification of alloantibody specificities. Hum Immunol 2010; 71: 462-7.
29. Norris PJ, Lee JH, Carrick DM, Gottschall JL, Lebedeva M, de Castro BR, Kleinman SH, Busch MP,. Long-term in vitro reactivity for human leukocyte antigen antibodies and comparison of detection using serum versus plasma. Transfusion 2009; 49: 243-51.